Filing Details
Minerva Neurosciences, Inc. (NASDAQ:NERV) filed its quarterly report (Form 10-Q) with the Securities and Exchange Commission on August 07, 2026.
The Healthcare company reported Q0 revenue of .
10q filedNASDAQ:NERV
Minerva Neurosciences, Inc. (NERV) Files Quarterly Report for Q0
Minerva Neurosciences, Inc. (NASDAQ:NERV) filed its quarterly report (Form 10-Q) with the Securities and Exchange Commission on August 07, 2026.
At publication ·
What changed
Minerva Neurosciences, Inc. (NASDAQ:NERV) · 10q filed
- Form
- 10-Q
At a glance
Key takeaways
- Minerva Neurosciences, Inc. (NASDAQ: NERV) filed its quarterly report (Form 10-Q) on August 07, 2026, providing unaudited financial statements and management commentary on recent performance.
- The company's stock trades at $4.27 with a market capitalization of $29.0 million as of the filing date.
- The 10-Q filing contains timely information about emerging trends, updated risk factors, and changes in business conditions since the last annual filing.
Market Context
Minerva Neurosciences, Inc.'s stock currently trades at $4.27 with a market capitalization of $29.0M.
The 10-Q provides Minerva Neurosciences, Inc.'s quarterly financial update, including unaudited financial statements and management commentary on recent performance. While less detailed than the annual 10-K, the 10-Q often contains timely information about emerging trends, updated risk factors, and changes in business conditions since the last filing.
All SEC filings for Minerva Neurosciences, Inc. are publicly available through the SEC's EDGAR database. Investors can set up alerts for new filings to stay current on material developments.
Related Tools: View NERV Stock Page
Frequently Asked Questions
Where can I read NERV's SEC filings?
Browse all filings on our NERV SEC filings page.
What types of SEC filings does Minerva Neurosciences, Inc. file?
Public companies like Minerva Neurosciences, Inc. file annual reports (10-K), quarterly reports (10-Q), material events (8-K), and insider transactions (Form 4) with the SEC.